{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T06:40:13Z","timestamp":1772692813417,"version":"3.50.1"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Child Adolesc. Psychiatry"],"abstract":"<jats:p>At this time, there is no report of how gabapentin may promote language development in children with autism spectrum disorder (ASD) experiencing neuropathic pain. A clinically significant increase in expressed vocabulary, around 10 words when gabapentin was prescribed to around 150 words at the 6-month follow-up, was observed in a child with ASD. This was likely due to improved symptoms of neuropathic pain, which could have allowed the patient to more effectively focus on language acquisition. Given that speech therapy had failed for years at that time to improve the patient's vocabulary and had been discontinued prior to and during the observed increase in expressive vocabulary, it was hypothesized a more direct neural effects of gabapentin could have contributed to the increase in verbal fluency. For instance, one could hypothesize that an increase in tonic, inhibitory conductance in neurons and increased stabilization of the neuronal membrane potential could negate atypical oscillatory activity observed in patients with ASD, thereby allowing for more effective learning processing. Neurodevelopmental outcomes following this reduction of atypical oscillatory activity may be mediated by thought differentiation, or cognitive defusion. Rather than cognitive defusion being an instructed state of mind as it is in psychotherapy research, it may be increased resolution to perception that is interoceptive awareness with large language models (LLMs) in neurodevelopment of the psychophysics of the neural effect, with clinical implications for the treatment of ASD.<\/jats:p>","DOI":"10.3389\/frcha.2026.1685978","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T05:25:24Z","timestamp":1772688324000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Gabapentin may promote language development in a pediatric patient with autism spectrum disorder: a case report"],"prefix":"10.3389","volume":"5","author":[{"given":"Tobias","family":"Kremsmayer","sequence":"first","affiliation":[{"name":"University of Illinois Chicago College of Medicine","place":["Chicago, IL, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Blakey","sequence":"additional","affiliation":[{"name":"Psychology, University of Bath","place":["Bath, United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo","family":"Hidrogo","sequence":"additional","affiliation":[{"name":"University of Illinois Chicago College of Medicine","place":["Chicago, IL, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolas","family":"Mata-Machado","sequence":"additional","affiliation":[{"name":"Pediatric Neurology, University of Illinois Chicago","place":["Chicago, IL, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"S55","DOI":"10.21037\/tp.2019.09.09","article-title":"Autism spectrum disorder: definition, epidemiology, causes, and clinical evaluation","volume":"9","author":"Hodges","year":"2020","journal-title":"Transl Pediatr"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1038\/s41598-023-28463-w","article-title":"Structural brain abnormalities and their association with language impairment in school-aged children with autism spectrum disorder","volume":"13","author":"Arutiunian","year":"2023","journal-title":"Sci Rep"},{"key":"B3","doi-asserted-by":"publisher","first-page":"3602","DOI":"10.1002\/hbm.22424","article-title":"Structural and functional underconnectivity as a negative predictor for language in autism","volume":"35","author":"Verly","year":"2014","journal-title":"Hum Brain Mapp"},{"key":"B4","doi-asserted-by":"publisher","first-page":"6779","DOI":"10.1523\/JNEUROSCI.0112-22.2023","article-title":"Speech reception in young children with autism is selectively indexed by a neural oscillation coupling anomaly","volume":"43","author":"Wang","year":"2023","journal-title":"J Neurosci"},{"key":"B5","doi-asserted-by":"publisher","first-page":"637079","DOI":"10.3389\/fnins.2021.637079","article-title":"Dysfunction of the auditory brainstem as a neurophysiology subtype of autism spectrum disorder","volume":"15","author":"Chen","year":"2021","journal-title":"Front Neurosci"},{"key":"B6","doi-asserted-by":"publisher","first-page":"102077","DOI":"10.1016\/j.pneurobio.2021.102077","article-title":"Altered maturation and atypical cortical processing of spoken sentences in autism spectrum disorder","volume":"203","author":"Alho","year":"2021","journal-title":"Prog Neurobiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3390\/genes16040441","article-title":"MTHFR gene polymorphisms: a single gene with wide-ranging clinical implications-A review","volume":"16","author":"Araszkiewicz","year":"2025","journal-title":"Genes"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.2174\/1381612811319140008","article-title":"Methylenetetrahydrofolate reductase: biochemical characterization and medical significance","volume":"19","author":"Trimmer","year":"2013","journal-title":"Curr Pharm Des"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharep.2017.04.017","article-title":"Association between MTHFR variant and diabetic neuropathy","volume":"70","author":"Kakavand Hamidi","year":"2018","journal-title":"Pharmacol Rep"},{"key":"B10","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jns.2017.10.035","article-title":"Manifestations of neurological symptoms and thromboembolism in adults with MTHFR-deficiency","volume":"383","author":"Rommer","year":"2017","journal-title":"J Neurol Sci"},{"key":"B11","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/hmg\/10.5.433","article-title":"Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition","volume":"10","author":"Chen","year":"2001","journal-title":"Hum Mol Genet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1016\/j.celrep.2018.02.021","article-title":"The \u03b12\u03b4-1-NMDA receptor complex is critically involved in neuropathic pain development and gabapentin therapeutic actions","volume":"22","author":"Chen","year":"2018","journal-title":"Cell Rep"},{"key":"B13","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1124\/jpet.120.266056","article-title":"Analgesia with gabapentin and pregabalin may involve N-methyl-d-aspartate receptors, neurexins, and thrombospondins","volume":"374","author":"Taylor","year":"2020","journal-title":"J Pharmacol Exp Ther"},{"key":"B14","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s12272-013-0057-y","article-title":"Implications and mechanism of action of gabapentin in neuropathic pain","volume":"36","author":"Kukkar","year":"2013","journal-title":"Arch Pharm Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1177\/1073858416628793","article-title":"The anti-allodynic gabapentinoids: myths, paradoxes, and acute effects","volume":"23","author":"Alles","year":"2017","journal-title":"Neuroscientist"},{"key":"B16","doi-asserted-by":"publisher","first-page":"CD007938","DOI":"10.1002\/14651858.CD007938.pub4","article-title":"Gabapentin for chronic neuropathic pain in adults","volume":"6","author":"Wiffen","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"B17","doi-asserted-by":"publisher","first-page":"CD012536","DOI":"10.1002\/14651858.CD012536.pub2","article-title":"Antiepileptic drugs for chronic non-cancer pain in children and adolescents","volume":"8","author":"Cooper","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e023296","DOI":"10.1136\/bmjopen-2018-023296","article-title":"Non-inferiority double-blind randomised controlled trial comparing gabapentin versus tramadol for the treatment of chronic neuropathic or mixed pain in children and adolescents: the GABA-1 trial-a study protocol","volume":"9","author":"Kaguelidou","year":"2019","journal-title":"BMJ Open"},{"key":"B19","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/bf03395641","article-title":"An experimental test of a cognitive defusion exercise: coping with negative and positive self-statements","volume":"58","author":"Healy","year":"2008","journal-title":"Psychol Rec"}],"container-title":["Frontiers in Child and Adolescent Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frcha.2026.1685978\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T05:25:25Z","timestamp":1772688325000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frcha.2026.1685978\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":19,"alternative-id":["10.3389\/frcha.2026.1685978"],"URL":"https:\/\/doi.org\/10.3389\/frcha.2026.1685978","relation":{},"ISSN":["2813-4540"],"issn-type":[{"value":"2813-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]},"article-number":"1685978"}}